FBXL3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.68742797512778E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
7.50230000345908E-08 |
Normal-vs-Stage2 |
1.459870E-03 |
Normal-vs-Stage3 |
1.6269208202857E-12 |
Normal-vs-Stage4 |
1.62436730732907E-12 |
Stage1-vs-Stage2 |
6.188600E-01 |
Stage1-vs-Stage3 |
4.20230000000021E-05 |
Stage1-vs-Stage4 |
2.14719999558355E-08 |
Stage2-vs-Stage3 |
8.154100E-02 |
Stage2-vs-Stage4 |
1.140360E-02 |
Stage3-vs-Stage4 |
1.891370E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
3.50497408874162E-13 |
Normal-vs-AfricanAmerican |
4.29499991128068E-10 |
Normal-vs-Asian |
1.712170E-02 |
Caucasian-vs-AfricanAmerican |
1.482030E-01 |
Caucasian-vs-Asian |
7.848200E-01 |
AfricanAmerican-vs-Asian |
3.523200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.54209978120434E-13 |
Normal-vs-Female |
9.69380131721209E-11 |
Male-vs-Female |
7.096000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
5.185000E-04 |
Normal-vs-Age(41-60Yrs) |
1.61350000027483E-09 |
Normal-vs-Age(61-80Yrs) |
1.63613567139009E-12 |
Normal-vs-Age(81-100Yrs) |
6.03110000052531E-07 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.873200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.903400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.839800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.048560E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.834600E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.196200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
3.704800E-01 |
Normal-vs-Grade 2 |
5.88699999999331E-05 |
Normal-vs-Grade 3 |
1.62447832963153E-12 |
Normal-vs-Grade 4 |
1.62447832963153E-12 |
Grade 1-vs-Grade 2 |
3.923800E-01 |
Grade 1-vs-Grade 3 |
7.207600E-04 |
Grade 1-vs-Grade 4 |
6.13440000019061E-07 |
Grade 2-vs-Grade 3 |
7.26679999951685E-07 |
Grade 2-vs-Grade 4 |
6.35269614690515E-13 |
Grade 3-vs-Grade 4 |
6.16729999999288E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.182170E-03 |
Normal-vs-ccB subtype |
5.55111512312578E-16 |
ccA subtype-vs-ccB subtype |
1.66779999810629E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
8.31335000839317E-12 |
Normal-vs-N1 |
8.1899043102851E-11 |
N0-vs-N1 |
2.359500E-02 |
|
|